医学
膀胱癌
化疗
泌尿科
嵌合体(遗传学)
癌症
肿瘤科
内科学
生物化学
化学
基因
作者
Louis Lenfant,Ugo Pinar,Morgan Rouprêt,Thomas Seisen
标识
DOI:10.1016/j.eururo.2023.02.026
摘要
The efficacy of first-line intravesical chemotherapy for non-muscle-invasive bladder cancer has been tested in the neoadjuvant and chemoresection settings. However, the data available are highly heterogeneous and further high-quality studies are needed before its use can be embraced in either setting.
科研通智能强力驱动
Strongly Powered by AbleSci AI